Utah Resident Is First Zika-Linked Death in Continental U.S.

Share this content:
Utah Resident Is First Zika-Linked Death in Continental U.S.
Utah Resident Is First Zika-Linked Death in Continental U.S.

MONDAY, July 11, 2016 (HealthDay News) -- An elderly resident of Utah who died at the end of June is the first fatality in the continental United States linked to infection with the Zika virus, local health officials said Friday.

The resident, whose name and age were not revealed, had traveled to an undisclosed destination where Zika is endemic, CNN reported. In a news release, Dagmar Vitek, M.D., medical director for the Salt Lake County Health Department, said the patient "had an underlying medical condition and tested positive for Zika, so we know it contributed to [the death], but we don't know that it was the sole cause. It may not be possible to determine how the Zika infection contributed to the death."

Gary Edwards, executive director of the Salt Lake County Health Department, told CNN that his agency didn't realize that Zika was involved in the patient's case until a review of the death certificate.

The Utah case is not the first U.S. death to be linked to Zika. In February, a 70-year-old Puerto Rico man died from complications related to the virus, CNN noted. The Zika virus has also been linked to 1,132 U.S. cases of infection tied to travel outside the country. Right now there are no cases of the disease being transmitted within the continental United States, according to health officials.

More Information

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Single-Payer Health System Bill Moves Forward in California

Single-Payer Health System Bill Moves Forward in California

Not yet clear where money for the single-payer system would come from

Regorafenib Approved for Hepatocellular Carcinoma

Regorafenib Approved for Hepatocellular Carcinoma

It is the first approved treatment for HCC in almost a decade

Three Anti-VEGF Treatments Effective for Diabetic Retinopathy

Three Anti-VEGF Treatments Effective for Diabetic Retinopathy

Rates of worsening low in patients receiving aflibercept, bevacizumab, or ranibizumab

is free, fast, and customized just for you!

Already a member?

Sign In Now »